Davidsyd, given the potential of the phase III, if it succeeds,...

Davidsyd, given the potential of the phase III, if it succeeds, the upside could be explosive. Other Hyact applications could drive the share price towards double digits, but probably on a 2-5 year horizon. I'm not personally going to get too excited about considering selling until past the $2 mark. That's if the phase III is successful. If it's not, then may have to take some medicine and sell at average cost or worse.